Barka Capital has announced a joint equity investment in Laboratoires Adeba, an Ivorian biocosmetics company founded by entrepreneur Linda Dempah. The investment was made alongside CDC-CI Capital, Côte d’Ivoire’s sovereign investment arm, marking a notable endorsement of a locally rooted consumer brand with regional and international ambitions. The announcement highlights growing investor interest in African-founded businesses that combine premium product positioning with measurable social and economic impact.
A Strategic Bet on Ivorian Biocosmetics
Laboratoires Adeba is developing a premium biocosmetics brand built around West African botanicals and Côte d’Ivoire’s natural resources. The company sources ingredients from women smallholder farmers, placing local supply chains and rural economic participation at the center of its model. By linking beauty, agriculture, and impact-driven entrepreneurship, Adeba is positioning itself within a fast-growing market for natural and ethically sourced personal care products.
Barka Capital described the company as fitting closely with its investment mandate, emphasizing founder-led execution, local roots, and the potential to compete beyond domestic borders. The Abidjan-based investor operates as both an accelerator and seed impact fund, backing early-stage ventures with growth potential and social relevance. Its participation alongside CDC-CI Capital signals confidence in Adeba’s commercial prospects and the broader opportunity for Côte d’Ivoire to build stronger consumer brands from indigenous resources.
Public Announcement in Abidjan
The commitment was announced during the closing ceremony of the third Foire Nationale de l’Emploi et du Recrutement in Abidjan. The event was attended by Côte d’Ivoire’s Vice Prime Minister Téné Birahima Ouattara, giving the announcement added public visibility. Barka Capital framed the moment as a milestone for the firm and a recognition of the work already undertaken by Dempah and the Adeba team.
The presence of CDC-CI Capital also gives the deal institutional weight, as the sovereign investment arm plays a role in supporting national economic priorities. For Adeba, the joint backing may help strengthen production capacity, brand development, market access, and supply chain organization. It also places the company within a wider national agenda focused on entrepreneurship, job creation, value addition, and the promotion of Ivorian businesses.
Founder-Led Growth and Local Supply Chains
Linda Dempah’s role as founder is central to the company’s story and to the investment rationale presented by Barka Capital. Adeba is not simply importing a cosmetics concept into the Ivorian market, but building a brand from local botanical ingredients and community-based sourcing. This gives the venture a distinctive identity at a time when consumers increasingly look for authenticity, traceability, and natural formulations.
The sourcing model involving women smallholder farmers adds an important development dimension to the business. If scaled effectively, Adeba’s growth could create more stable demand for locally produced botanical inputs while increasing income opportunities for farming communities. That impact narrative strengthens the company’s appeal to investors seeking both financial returns and inclusive economic outcomes.
Investor Confidence in African Consumer Brands
The deal reflects a broader shift in African private capital toward consumer-facing companies that can turn local production advantages into differentiated brands. Beauty and personal care remain highly competitive sectors, but businesses with strong sourcing stories, clear founder leadership, and credible quality standards can carve out defensible positions. Adeba’s emphasis on West African botanicals gives it a platform to appeal to domestic consumers while also exploring regional and international markets.
For Barka Capital, the investment aligns with its stated focus on backing companies that are embedded in local economies yet capable of reaching global standards. For CDC-CI Capital, the partnership supports a business that connects entrepreneurship, agriculture, women’s economic participation, and industrial value creation. Together, the investors are placing a bet on the ability of Ivorian innovation to move higher up the value chain.
The joint investment in Laboratoires Adeba is a significant development for Côte d’Ivoire’s emerging biocosmetics sector and for founder-led consumer entrepreneurship in the country. By backing a brand built from West African botanicals and sourced through women smallholder farmers, Barka Capital and CDC-CI Capital are supporting a business model that blends market ambition with local impact. As Adeba enters its next phase, its progress will be watched as a test case for how African natural-resource-based brands can scale with quality, authenticity, and institutional investor support.